Entera Bio Ltd.
Quick facts
Phase 3 pipeline
- Oral PTH (1-34) · Endocrinology / Bone Metabolism
Oral PTH (1-34) activates parathyroid hormone receptors on bone cells to stimulate bone formation and increase bone mineral density.
Phase 2 pipeline
- EBP05 · Gastroenterology
EBP05 is a recombinant human glucagon-like peptide-2 (GLP-2) analog.
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Entera Bio Ltd.
What is Entera Bio Ltd.'s pipeline?
Entera Bio Ltd. has 1 drugs in Phase 3, 1 in Phase 2, 6 in Phase 1. Late-stage candidates include Oral PTH (1-34).
Related
- Sector hub: All tracked pharma companies